Analysis on Drug Therapy in a Patient with In-stent Restenosis / 中国药学杂志

ABSTRACT

OBJECTIVE: To discuss the drug therapy in a patient with in-stent restenosis, and explore the work forms of pharmacists in the department of cardiology. METHODS: Two causes for in-stent restenosis were summarized by pharmacists, which the patient was noncompliance or poor quality of drugs. Then pharmacists gave feasible suggestions to improve drug therapy by searching literatures and consulting patients. RESULTS: After regular administration of aspirin in our hospital, the symptoms improved and laboratory test showed poor. The outcome of follow-up in 5th month is normal. CONCLUSION: Pharmacists identify adverse events and help physicians to make individual drug therapy to ensure patient safety, effectiveness and economy.